Zions Bancorporation, N.A. Oncolytics Biotech Inc Transaction History

Zions Bancorporation, N.A.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 05, 2022	SELL	$0.85 - $1.59 $4,250 - $7,950	-5,000 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$2.32 - $4.11 $11,600 - $20,550	5,000 New	5,000 $19,000

1.41M

Ticker ONCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,867,400
Market Cap $57.3M
Description
Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a...

Get notified when there are updates to the investment portfolio of Zions Bancorporation, N.A., based on Form 13F filings with the SEC.

Stay updated on Zions Bancorporation, N.A. with notifications on news.